Tourmaline Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tourmaline Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q1 2025.
  • Tourmaline Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $2.27M, a 63.8% increase year-over-year.
  • Tourmaline Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $7.48M, a 10.6% increase year-over-year.
  • Tourmaline Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $6.59M, a 14.3% increase from 2023.
  • Tourmaline Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.77M, a 2858% increase from 2022.
  • Tourmaline Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $195K, a 94.8% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.